Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/11033
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDhas, Namdev-
dc.contributor.authorMehta, Tejal-
dc.contributor.authorKudarha, Rita et al.-
dc.date.accessioned2022-03-21T07:59:36Z-
dc.date.available2022-03-21T07:59:36Z-
dc.date.issued2021-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/11033-
dc.descriptionJournal of Controlled Release 330 (2021) 257–283en_US
dc.description.abstractIn recent years, there have been significant advancements in the nanotechnology for cancer therapy. Even though molybdenum disulphide (MoS2)-based nanocomposites demonstrated extensive applications in biosensing, bioimaging, phototherapy, the review article focusing on MoS2 nanocomposite platform has not been accounted for yet. The review summarizes recent strategies on design and fabrication of MoS2-based nanocomposites and their modulated properties in cancer treatment. The review also discussed several therapeutic strategies (photothermal, photodynamic, immunotherapy, gene therapy and chemotherapy) and their combinations for efficient cancer therapy along with certain case studies. The review also inculcates various diagnostic techniques viz.magnetic resonance imaging, computed tomography, photoacoustic imaging and fluorescence imaging for diagnosis of cancer.en_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesIPFP0488;-
dc.subjectMolybdenum disulphideen_US
dc.subjectPhototherapyen_US
dc.subjectBiomedical applicationsen_US
dc.subjectChemotherapyen_US
dc.subjectMagnetic resonance imagingen_US
dc.subjectPhotoacoustic imagingen_US
dc.titleMolybdenum-Based Hetero-Nanocomposites for Cancer Therapy, Diagnosis and Biosensing Application: Current Advancement and Future Breakthroughsen_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0488.pdfIPFP04883.3 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.